CIK 0001622229 · Large accelerated filer
Cogent Biosciences, Inc.
Sign in to watch- Ticker
- COGT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 465308248
- Phone
- 617-945-5576
- Business address
- 180 THIRD AVENUE, 4TH FLOOR, WALTHAM, MA
- Former names
- Unum Therapeutics Inc., Unum Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,689,493
- in 1 filing, $1.7M under 10b5-1 plans
Net −$1,689,493. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 18 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-06-14 | PEREZ ROBERT J Director | Grant or award · Stock Option (Right to Buy) | +7,131 | $1.67 | $12K | 7,131 |
| 2019-04-24 | Green John L. See Remarks | Grant or award · Stock Option (Right to Buy) | +16,814 | 16,814 | ||
| 2019-04-19 | Green John L. See Remarks | Grant or award · Stock Option (Right to Buy) | +21,017 | 21,017 | ||
| 2019-04-01 | Ratcliffe Liam Director | Grant or award · Stock Option (Right to Buy) | +4,829 | $2.72 | $13K | 4,829 |
| 2019-04-01 | PEREZ ROBERT J Director | Grant or award · Stock Option (Right to Buy) | +4,369 | $2.72 | $12K | 4,369 |
| 2019-04-01 | Ferrante Karen Jean Director | Grant or award · Stock Option (Right to Buy) | +4,047 | $2.72 | $11K | 4,047 |
| 2019-04-01 | Booth Bruce Director | Grant or award · Stock Option (Right to Buy) | +6,714 | $2.72 | $18K | 6,714 |
| 2019-04-01 | Aldag Jorn Director | Grant or award · Stock Option (Right to Buy) | +4,966 | $2.72 | $14K | 4,966 |
| 2019-03-25 | Ettenberg Seth Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −11,485 | 329,145 | ||
| 2019-03-25 | Ettenberg Seth Chief Scientific Officer | Option exercise | +11,485 | $0.18 | $2K | 11,485 |
| 2019-03-25 | Ettenberg Seth Chief Scientific Officer | Sale | −11,485 | $4.12 | $47K | 0 |
| 2019-03-25 | Ettenberg Seth Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +11,485 | 329,145 | ||
| 2019-03-01 | WILSON CHARLES Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +174,400 | 174,400 | ||
| 2019-03-01 | VASCONCELLES MICHAEL Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +61,900 | 61,900 | ||
| 2019-03-01 | HODGE GEOFFREY Chief Technical Officer | Grant or award · Stock Option (Right to Buy) | +28,000 | 28,000 | ||
| 2019-03-01 | Green John L. See Remarks | Grant or award · Stock Option (Right to Buy) | +21,017 | 21,017 | ||
| 2019-03-01 | Ettenberg Seth Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +69,700 | 69,700 | ||
| 2019-02-25 | Ettenberg Seth Chief Scientific Officer | Option exercise | +11,485 | $0.18 | $2K | 11,485 |
| 2019-02-25 | Ettenberg Seth Chief Scientific Officer | Sale | −11,485 | $4.25 | $49K | 0 |
| 2019-02-25 | Ettenberg Seth Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −11,485 | 340,630 |
Page 13 of 14 · 268 trades